Perinatal Psychiatry: Treatment During Pregnancy and the Postpartum will focus on the diagnosis and treatment of psychiatric disorders in women across pregnancy and postpartum. Specialized knowledge is necessary to tailor treatments to reproductive events such as pregnancy, pregnancy planning, and postpartum. Exposure to psychotropic medications and the consequences of untreated psychiatric disorders must be considered when treating pregnant women, those who may become pregnant during treatment, and those who are breastfeeding. Up-to-date and comprehensive knowledge is required to help patients make collaborative and individualized treatment decisions. A strong understanding of the literature pertaining to the reproductive safety of medications is imperative to factor in the potential risks and benefits of medication, and context is particularly critical in putting risks into perspective. Focused material will be presented regarding specialized psychotherapies utilized during pregnancy and postpartum, as well as an overview of embryology and obstetrics, informing a broad range of care modalities.
For each activity you select in the Register tab:
This site is operated and maintained by The Massachusetts General Hospital Psychiatry Academy. No material or information from this site may be copied, reproduced, republished, uploaded, posted, transmitted, or distributed unless approved in writing by The Psychiatry Academy. Questions concerning the proper use of materials and information on this site should be directed to mghcme@mgh.harvard.edu. No rights or licenses of any kind of The Psychiatry Academy’s intellectual property are transferred to, granted to, provided to, or received by you as a result of using this website.
A $100.00 administrative fee will be applied.
This program is intended for:
By the end of this program, participants will be able to:
In support of improving patient care, MGH Institute of Health Professions is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
5.25 Psychologists
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs. MGH Institute of Health Professions designates this activity for 5.25 CE credit.
5.25 Physicians
MGH Institute of Health Professions designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity.
5.25 Nursing
MGH Institute of Health Professions designates this activity for 5.25 contact hours for nurses.
5.25 Social Workers
As a Jointly Accredited Organization, the MGH Institute of Health Professions is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. MGH Institute of Health Professions maintains responsibility for this course. Social workers completing this course receive 5.25 clock hours for continuing education credits.
5.25 IPCE Credit
This activity was planned by and for the healthcare team, and learners will receive 5.25 Interprofessional Continuing Education (IPCE) credits for learning and change.
Participants must complete each Module and must complete all components to receive credit, including:
PROGRAM AGENDA (2025)
Psychiatric Disorders During Pregnancy
Lee S. Cohen, MD
Postpartum Mood and Anxiety Disorders
Marlene P. Freeman, MD
Premenstrual Dysphoric Disorder (PMDD)
Laura Fagioli Petrillo, EdM, MD
Menopause and Mood: Clinical Insights into Midlife Mental Health
Ruta Nonacs, MD, PhD
ADHD in Women: Focus on the Reproductive Years
Allison Baker, MD
Substance Use Disorders in The Perinatal Period: Pharmacological Treatment
Edwin Raffi, MD, MPH
Psychiatric Emergencies During Pregnancy and Postpartum
Annika Holmberg, PMHNP-BC
Lee S. Cohen, MD
Marlene P. Freeman, MD
Lee S. Cohen, MD
Marlene P. Freeman, MD
Laura Fagioli Petrillo, EdM, MD
Ruta Nonacs, MD, PhD
Allison Baker, MD
Edwin Raffi, MD, MPH
Annika Holmberg, PMHNP-BC
Policy on Faculty and Provider Disclosure:
Disclosure Information
In accordance with the disclosure policy of MGH Institute of Health Professions as well as guidelines set forth by the Accreditation Council on Continuing Medical Education, all people in control of educational content, including speakers, course directors, planners, and reviewers, have been asked to disclose all financial relationships with ineligible companies for the past 24 months, as defined below:
Ineligible Companies
The ACCME defines an “Ineligible company” as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.” For more information, visit accme.org/standards.
Financial Relationships
Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options, or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.
Mitigation of Financial Relationships
All financial relationships are reviewed to determine which ones are relevant, and then measures are taken to mitigate all relevant financial relationships and ensure that they do not insert commercial bias into the content of the education.
Conflict of Interest
Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of a commercial interest with which he/she has a financial relationship. The following planners, speakers, and content reviewers, on behalf of themselves and their spouse or partner, have reported financial relationships with an entity producing, marketing, re-selling, or distributing healthcare goods or services (relevant to the content of this activity) consumed by, or used on, patients:
Susan Sprich, PhD
Royalties (Co-Author): Oxford University Press
Royalties (Co-Edited Book): Springer
Honoraria (Associate Editors): Association for Behavioral and Cognitive Therapies (ABCT)
All other individuals, including course directors, planners, reviewers, faculty, staff, etc., who are in a position to control the content of this educational activity have, on behalf of themselves and their spouse or partner, reported no financial relationships related to the content of this activity.
Marlene P. Freeman, MD
Investigator-Initiated Trials (Research): JayMac, Sage
Advisory Board: Otsuka, Alkermes, Sunovion Pharmaceuticals
Independent Data Safety and Monitoring Committee (Honoraria): Janssen (Johnson& Johnson)
Dr. Freeman is an employee of Massachusetts General Hospital and works with the MGH National Pregnancy Registry [Current Registry Sponsors]: Teva, Alkermes, Inc., Otsuka America Pharmaceutical, Inc., Forest/Actavis, Sunovion Pharmaceuticals, Inc.
Steering Committee for Educational Activities: Medscape
Lee S. Cohen, PhD
Research Support: National Pregnancy Registry for Psychiatric medications, Alkermes Biopharmaceuticals; Aurobindo Pharma; Auromedics Pharma LLC; Janssen Pharmaceutica; Otsuka Pharmaceuticals, Inc; Supernus Pharmaceuticals
Other Research Support: Brain & Behavior Research Foundation; JayMac Pharmaceuticals; National Institute on Aging; National Institutes of Health; SAGE Therapeutics
Advisory/Consulting (through MGH Clinical Trials Network Initiative): Alkermes Biopharmaceuticals; Praxis Precision Medicines, Inc.
All other individuals in a position to control the content of this educational activity have reported no financial relationships with ineligible companies.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.
McLean Hospital designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.
This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 5.25 contact hours of nursing continuing education credit.
Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation.
The Collaborative of NASW, Boston College, and Simmons College Schools of Social Work authorizes social work continuing education credits for courses, workshops, and educational programs that meet the criteria outlined in 258 CMR of the Massachusetts Board of Registration of Social Workers
This program has been approved for 5.25 Social Work Continuing Education hours for relicensure, in accordance with 258 CMR.
Collaborative of NASW and the Boston College and Simmons Schools of Social Work Authorization Number D90156.
This course allows other providers to claim a Participation Certificate upon successful completion of this course.
Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists.
The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content. This offering meets the criteria for 5.25 Continuing Education (CE) credits per presentation for psychologists.
Release Date: January 23, 2021
Expiration Date: February 7, 2028
Review Date: January 23, 2022 by Robert Althoff, MD, PhD
We have a dedicated staff member who is available by phone 5 days per week between 8 am and 5 pm by calling 866-644-7792 or email at mghcme@mgh.harvard.edu. All inquiries will be dealt with in a timely (within one business day) and professional manner. Requests for credits or refunds will be reviewed by the Director of the Division of Professional and Public Education, Massachusetts General Hospital. Please refer to our cancellation policy for additional information.”